United States · FDA National Drug Code directory
Mesalamine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-1302_466a93ff-b90a-4e04-b440-8b26e3f95c63
- Product NDC
- 70710-1302
- Form
- SUPPOSITORY
- Composition / generic term
- Mesalamine
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200214
- Source listing expiry
- 20261231
Source-listed ingredients
- MESALAMINE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 BLISTER PACK in 1 POUCH (70710-1302-7) / 6 SUPPOSITORY in 1 BLISTER PACK (70710-1302-6) · 70710-1302-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →